ロード中...
Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS‐CoV‐2 infection and long COVID
BACKGROUND: COVID‐19 can present with lymphopenia and extraordinary complex multiorgan pathologies that can trigger long‐term sequela. AIMS: Given that inflammasome products, like caspase‐1, play a role in the pathophysiology of a number of co‐morbid conditions, we investigated caspases across the s...
保存先:
| 出版年: | Allergy |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8222863/ https://ncbi.nlm.nih.gov/pubmed/33993490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.14907 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|